iPS Cell Differentiation

Scientists use two primary methods to differentiate iPS cells. In the first method, cells form three-dimensional clusters called embryoid bodies in culture medium supplemented with specific growth factors, which sequentially transform them into specialized cells like neurons or cardiomyocytes. In the second method, iPS cells grow on artificial scaffolds providing extracellular matrix proteins, allowing direct transformation into specialized cells without forming intermediate embryoid bodies.

Differentiation is induced by adding specific growth factors to the cell culture medium in a particular sequence at specific times. These molecules trigger specific differentiation pathways; for example, certain growth factors and vitamins trigger the neuronal differentiation pathway, transforming pluripotent cells into neural progenitor cells and eventually into terminally differentiated motor neurons.

An embryoid body is a three-dimensional cell cluster that forms when iPS cells are grown in culture medium. These structures serve as an intermediate stage in differentiation, sequentially transforming from pluripotent cells into specialized cell types. When grown in medium supplemented with specific molecules, embryoid bodies differentiate into various cell types including neurons and other specialized cells.

Skin cells from an AMD patient were reprogrammed to form iPS cells, then differentiated into retinal pigment epithelium cells. When transplanted into the patient's retina, these newly formed RPE cells restored vision. This demonstrates how eps and ips cells in disease research can address tissue loss caused by aging and degenerative conditions.

Yes. Bone marrow stromal cells from a sickle cell patient were reprogrammed into iPS cells, and the mutation causing the sickle cell phenotype was corrected using the CRISPR-Cas system. When these corrected iPS cells were differentiated into erythroid cells, they expressed normal β-globin protein, demonstrating genetic correction potential for inherited blood disorders.

iPS cells can differentiate into various specialized cell types including pancreatic beta cells, liver cells, cardiomyocytes, neurons, motor neurons, retinal pigment epithelium cells, and erythroid cells. This versatility makes iPS cells valuable for regenerative medicine, allowing repair of damaged tissues in conditions like diabetes, neurodegenerative disorders, and blood diseases.

Artificial scaffolds provide extracellular matrix proteins that support iPS cell growth and allow direct transformation into specialized cells without forming intermediate embryoid bodies. This method streamlines the differentiation process, potentially reducing the time and complexity required to generate specific cell types for therapeutic applications.